2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-090)(COMPLETED)
Clinical trial NCT00090155 · COMPLETED
Trial details
- NCT number
- NCT00090155
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-09-26
- Primary completion
- 2004-11-24
- Enrollment
- 805
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.